Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 7Carcinoma, Non-Small-Cell Lung 4Triple Negative Breast Neoplasms 3Hodgkin Disease 3Rhabdomyosarcoma, Embryonal 2Rhabdomyosarcoma, Alveolar 2Rhabdomyosarcoma 2Neoplasm Metastasis 2Uterine Cervical Neoplasms 1Sarcoma 1Recurrence 1Neoplasms 1Lung Neoplasms 1Lung Diseases, Interstitial 1HR+HER2- Breast Cancer 1Desmoplastic Small Round Cell Tumor 1Adenocarcinoma 1

Interventions

PM 01183 2Cyclophosphamide 2pembrolizumab 1fludarabine phosphate 1fludarabine 1Vinorelbine 1Ramucirumab 1Mesna 1Irinotecan 1CLR1404 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Desmoplastic Small Round Cell Tumor × Vinorelbine × 90 days × Clear all
NCT04145349 2026-05-11

CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor

Eli Lilly and Company

Phase 1/2 Completed
30 enrolled 16 charts
Sarcoma

Sarcoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡